| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Access to hospital care, clinical stage and survival from colorectal cancer according to socio-economic status
|
Ciccone, G.
|
|
2000
|
11 |
9 |
p. 1201-1204
|
artikel
|
| 2 |
Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease
|
Engel, C.
|
|
2000
|
11 |
9 |
p. 1105-1114
|
artikel
|
| 3 |
Anaplastic thyroid carcinoma: Current diagnosis and treatment
|
Giuffrida, D.
|
|
2000
|
11 |
9 |
p. 1083-1089
|
artikel
|
| 4 |
A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: Correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints
|
Ferry, D. R.
|
|
2000
|
11 |
9 |
p. 1165-1170
|
artikel
|
| 5 |
A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix
|
Herod, J.
|
|
2000
|
11 |
9 |
p. 1175-1181
|
artikel
|
| 6 |
Aspirin and ovarian cancer: An Italian case-control study
|
Tavani, A.
|
|
2000
|
11 |
9 |
p. 1171-1173
|
artikel
|
| 7 |
Breast cancer and the axilla: Not entirely out of the labyrinth
|
Costa, A.
|
|
2000
|
11 |
9 |
p. 1081-1082
|
artikel
|
| 8 |
Cancer mortality up, life expectancy down in Eastern Europe; Tobacco companies tried to destroy WHO; Roche closes down prestigious institute; More money for the NHS: Will it work better?; US administration halts cancer tests in Oklahoma; Perhaps not everyone knows that...
|
|
|
2000
|
11 |
9 |
p. 1073-1077
|
artikel
|
| 9 |
Distal ischemic changes related to combination chemotherapy with cisplatin and gemcitabine: Description of four cases
|
Barceloó, R.
|
|
2000
|
11 |
9 |
p. 1191-1194
|
artikel
|
| 10 |
Effect of single chemotherapeutic agents on the growing skeleton of the rat
|
van Leeuwen, B. L.
|
|
2000
|
11 |
9 |
p. 1121-1126
|
artikel
|
| 11 |
GM-CSF with biochemotherapy (cisplatin, DTIC, tamoxifen, IL-2 and interferon-alpha): A phase I trial in melanoma
|
Vaughan, M. M.
|
|
2000
|
11 |
9 |
p. 1183-1189
|
artikel
|
| 12 |
Hepatocellular carcinoma after long-term tamoxifen therapy
|
Moffat, D. F.
|
|
2000
|
11 |
9 |
p. 1195-1196
|
artikel
|
| 13 |
Identification of prognostic subgroups among patients with metastatic `IGCCCG poor-prognosis' germ-cell cancer: An explorative analysis using cart modeling
|
Kollmannsberger, C.
|
|
2000
|
11 |
9 |
p. 1115-1120
|
artikel
|
| 14 |
Impact of nodal status on indication for adjuvant treatment in clinically node negative breast cancer
|
Greco, M.
|
|
2000
|
11 |
9 |
p. 1137-1140
|
artikel
|
| 15 |
Infections and human cancer
|
Newton, R.
|
|
2000
|
11 |
9 |
p. 1079-1080
|
artikel
|
| 16 |
Inflammatory demyelinating polyneuropathy: A complication of immunotherapy in malignant melanoma
|
Anthoney, D. A.
|
|
2000
|
11 |
9 |
p. 1197-1200
|
artikel
|
| 17 |
Is there a range of time for initiation of adjuvant chemotherapy inpatients with malignancy?
|
Altundağ, M. K.
|
|
2000
|
11 |
9 |
p. 1209
|
artikel
|
| 18 |
Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: Follow-up study and prognostic significance
|
Gonzalez, R.
|
|
2000
|
11 |
9 |
p. 1097-1104
|
artikel
|
| 19 |
Multimodality therapy in inflammatory breast cancer: Is there a place for surgery?
|
De Boer, R. H.
|
|
2000
|
11 |
9 |
p. 1147-1153
|
artikel
|
| 20 |
N. Karssemeijer, M. Thijssen, J. Hendriks & L. van Erning (eds)., Digital Mammography, Nijmegen 1998
|
Alerci, M.
|
|
2000
|
11 |
9 |
p. 1210
|
artikel
|
| 21 |
Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide
|
Ricci, S.
|
|
2000
|
11 |
9 |
p. 1127-1130
|
artikel
|
| 22 |
Phase I and pharmacological study of increased dose oral topotecan in combination with intravenous cisplatin
|
Gelderblom, A. J.
|
|
2000
|
11 |
9 |
p. 1205-1207
|
artikel
|
| 23 |
Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255
|
Lichtman, S. M.
|
|
2000
|
11 |
9 |
p. 1141-1146
|
artikel
|
| 24 |
Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junction
|
Sandler, A. B.
|
|
2000
|
11 |
9 |
p. 1161-1164
|
artikel
|
| 25 |
Primary care physicians' knowledge and attitudes towards genetic testing for breast–ovarian cancer predisposition
|
Escher, M.
|
|
2000
|
11 |
9 |
p. 1131-1135
|
artikel
|
| 26 |
P. van Houtte (ed)., Progress and Perspectives in the Treatment of Lung Cancer
|
Bodis, S.
|
|
2000
|
11 |
9 |
p. 1078
|
artikel
|
| 27 |
Strategies to reduce the risk of virus-related cancers
|
Franceschi, S.
|
|
2000
|
11 |
9 |
p. 1091-1096
|
artikel
|
| 28 |
Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines
|
Vassilomanolakis, M.
|
|
2000
|
11 |
9 |
p. 1155-1160
|
artikel
|
Tijdschrift beschrijving